Steven David Kummer

Title: Innovations by Steven David Kummer

Introduction

Steven David Kummer is an accomplished inventor based in Canastota, NY (US). He has made significant contributions to the field of medical devices, particularly in the area of cancer treatment. His innovative work focuses on improving the delivery of chemotherapy drugs, which is crucial for effective bladder cancer treatment.

Latest Patents

Kummer holds a patent for the "Mitomycin-C bladder instillation syringe kit." This invention provides compositions, methods, and devices for delivering Mitomycin-C (MMC), an antineoplastic chemotherapy drug. The formulation is designed to maintain stability in both acidic and alkaline environments, ensuring effective treatment for bladder cancer. The buffered MMC solution, combined with 50% propylene glycol, maintains a pH from 7.0 to 8.0 when introduced into acidic solutions. This innovative kit can be produced in an FDA registered 503B Outsourcing facility, making it ready for administration with the necessary accessories for bladder instillation.

Career Highlights

Kummer is currently associated with Edge Pharma, LLC, where he continues to develop and refine medical solutions. His work has been instrumental in advancing the field of oncology, particularly in the delivery methods of chemotherapy drugs.

Collaborations

Kummer collaborates with talented professionals in his field, including Melissa Lee Bainbridge and Brian Thomas Badgley. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Steven David Kummer's contributions to medical device innovation, particularly in cancer treatment, highlight the importance of effective drug delivery systems. His work continues to impact the lives of patients undergoing treatment for bladder cancer.